Pharmacometric analyses and clinical evidence for brigatinib dosing in anaplastic lymphoma kinase‐positive non‐small cell lung cancer

Detalles Bibliográficos
Autores principales: Gupta, Neeraj, Hanley, Michael J., Sinha, Vikram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286636/
https://www.ncbi.nlm.nih.gov/pubmed/35350085
http://dx.doi.org/10.1111/bcp.15322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286636/
https://www.ncbi.nlm.nih.gov/pubmed/35350085
http://dx.doi.org/10.1111/bcp.15322

Ejemplares similares